
Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease
Keywords: neuroprotection; inflammation; immunocytochemistry; striatum; substantia nigra; tyrosine hydroxylase; Alb; albumin; ANOVA; factor analysis of variance; CR3; complement receptor type 3; DAT; dopamine transporter; EPO; erythropoietin; GFAP; glial fibrillary